Portfolio (Quarterly)
Guide ↗
GF FUND MANAGEMENT CO. LTD.
· CIK 0002057060| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 561 | LYEL | Lyell Immunopharma Inc | Healthcare | 452.0 | $6K | — | NEW | — | $14.05 | +9.1% |
| 562 | TKNO | Alpha Teknova Inc | Healthcare | 1,111.0 | $6K | — | NEW | — | $5.68 | +30.2% |
| 563 | FHTX | Foghorn Therapeutics Inc | Healthcare | 1,241.0 | $6K | — | NEW | — | $4.88 | +43.9% |
| 564 | TRDA | Entrada Therapeutics Inc | Healthcare | 812.0 | $6K | — | NEW | — | $7.36 | +1.4% |
| 565 | NMRA | Neumora Therapeutics Inc | Healthcare | 3,471.0 | $6K | — | NEW | — | $1.70 | -9.7% |
| 566 | SIGA | SIGA Technologies Inc | Healthcare | 1,487.0 | $5K | — | NEW | — | $3.64 | -17.7% |
| 567 | — | Apartment Investment and Manag | — | 1,762.0 | $5K | — | NEW | — | $2.97 | — |
| 568 | IVVD | Invivyd Inc | Healthcare | 5,929.0 | $5K | — | NEW | — | $0.87 | +8.5% |
| 569 | FULC | Fulcrum Therapeutics Inc | Healthcare | 1,411.0 | $5K | — | NEW | — | $3.66 | +5.5% |
| 570 | AVXL | Anavex Life Sciences Corp | Healthcare | 1,964.0 | $5K | — | NEW | — | $2.59 | +38.9% |
| 571 | OBIO | Orchestra BioMed Holdings Inc | Healthcare | 1,173.0 | $5K | — | NEW | — | $4.32 | +25.4% |
| 572 | ACIU | AC Immune SA | Healthcare | 2,084.0 | $5K | — | NEW | — | $2.38 | +22.7% |
| 573 | NBP | NovaBridge Biosciences | Healthcare | 2,377.0 | $5K | — | NEW | — | $1.95 | -3.1% |
| 574 | CHRS | Coherus Oncology Inc | Healthcare | 3,164.0 | $4K | — | NEW | — | $1.40 | -0.7% |
| 575 | VYGR | Voyager Therapeutics Inc | Healthcare | 1,245.0 | $4K | — | NEW | — | $3.50 | -0.2% |
| 576 | CDXS | Codexis Inc | Healthcare | 1,913.0 | $4K | — | NEW | — | $2.26 | -25.0% |
| 577 | ARCT | Arcturus Therapeutics Holdings | Healthcare | 611.0 | $4K | — | NEW | — | $6.72 | +124.0% |
| 578 | — | Lifecore Biomedical Inc | — | 779.0 | $4K | — | NEW | — | $5.25 | — |
| 579 | BCYC | Bicycle Therapeutics PLC | Healthcare | 962.0 | $4K | — | NEW | — | $4.24 | +3.5% |
| 580 | LENZ | LENZ Therapeutics Inc | Healthcare | 665.0 | $4K | — | NEW | — | $5.68 | -16.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
70.8%
Consumer Cyclical
9.0%
Communication Services
6.0%
Healthcare
4.5%
Consumer Defensive
3.9%
Industrials
1.9%
Energy
1.8%
Utilities
0.8%
Financial Services
0.6%
Basic Materials
0.6%